Continuing Education
2026 RLS Educational Offerings
Professional development guided by experts
RLS is proud to offer a dynamic educational program designed to support the ongoing professional development of nuclear medicine and radiopharmacy professionals. Each course in this series is accredited for SNMMI VOICE credit, and participants who successfully complete an activity will earn 1.0 Continuing Education Hour (CEH).
Led by subject matter experts, these sessions provide timely, clinically relevant insights into radiopharmaceutical science, regulatory updates, and best practices in nuclear medicine. Whether you’re looking to deepen your expertise, stay current with industry standards, or maintain certification, the RLS Educational Series delivers high-quality content tailored to your professional needs.
To receive VOICE credit, participants must first complete the activity/course content. When completed, participants must take the post-activity/course assessment. Participants must obtain a score of 80% to receive the VOICE credit. Participants will have no more than 3 attempts to successfully complete the test.
Programs offered
1.
Gastric Emptying Best Practices: The New GLP-1 Drugs and Changes (August 2024 – August 2026)
Objectives:
- Understand the anatomy and physiology of the stomach and how certain GLP-1 drugs affect gastric motility
- List the recommended parameters and processing when performing GES to ensure high-quality scans
- State the best practices regarding meal preparation when performing GES according to the JNMT literature
2.
Cardiac Amyloidosis Imaging: A Look at Subtypes (AL and ATTR) and Tc99m PYP or HDP (July 2024 – July 2026)
Objectives:
- Understand CA and the different types of CA
- Understand the treatment options for each type of CA
- Understand the diagnostic tests available and explain the grading system for SPECT imaging
3.
I-123 loflupane Best Practices: Understanding Parkinson’s Disease, Neurotransmitters, and Achieving High-Quality Images (July 2024 – July 2026)
Objectives:
- Describe the chemical structure and mechanism of action, pharmacokinetics, and the clinical indications for imaging
- List the 3 best practices for achieving high-quality I-123 ioflupane images
- Understand the normal and abnormal I-123 ioflupane images
4.
Cardiac PET: History of MPI Tracers, Current FDA-Approved Cardiac PET Tracers, SPECT vs PET, and Protocols (February 2025 – March 2027)
Objectives:
- Understand the history of MPI tracers and the current FDA-approved cardiac PET tracers
- Explain the advantages of cardiac PET over SPECT for MPI
- Understand the importance of myocardial blood flow, reserve flow, and calcium scoring to better inform patient management decisions
5.
PET Radiopharmaceutical Development and Production (November 2025 – November 2027)
Objectives:
- Introduction of PET
- Production of radionuclides for PET and PET generators
- Cyclotrons and necessary QC
6.
Molecular Imaging of Gliomas: The Past, the Present, and the Future (March 2026 – March 2028)
Objectives:
- Understand the historical timeline of gliomas, including pathophysiology and evolution of imaging methods
- Identify FDA-approved and research brain radiopharmaceuticals for imaging of the brain
- Understand the importance of high sensitivity and specificity of molecular imaging of the brain to help guide better patient management decisions
CA, cardiac amyloidosis; FDA, U.S. Food and Drug Administration; GES, gastric emptying scintigraphy; JNMT, Journal of Nuclear Medicine Technology; MPI, myocardial perfusion imaging; PET, positron emission tomography; QC, quality control; SPECT, single‑photon emission computed tomography.
Katrina Beckett, MHA, CNMT
Katrina, our Southeast Account Manager, has been with RLS for 6 years. With over 25 years in the medical field, she’s worked in all 3 nuclear medicine modalities. She’s a continuing education specialist, new hire trainer, and adjunct facilitator for the University of Cincinnati’s MHA program. Since 2017, she has served on SNMMI’s Quality Committee, proudly giving back to the nuclear medicine community.
Please contact Katrina or your RLS representative to schedule a program
RLS is proud to collaborate with some of the most revered and important names in the radiopharmaceutical field
The Joint Commission accredits and certifies more than 20,000 healthcare organizations in the United States, setting rigorous standards for quality and patient safety.
NANP (National Association of Nuclear Pharmacies)
NMEU (Nuclear Medicine Europe)
SNMMI (Society of Nuclear Medicine and Molecular Imaging)
SNMMI is an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and radiopharmaceutical therapies. SNMMI establishes guidelines, promotes research, and sets practice standards that drive innovation and excellence in precision medicine and patient care.
ASNC (American Society of Nuclear Cardiology)
ASNC is the international leader in education, advocacy, and quality standards for cardiovascular imaging, including nuclear cardiology and radiopharmaceuticals. It provides critical expertise and promotes best practices in cardiac imaging and therapy.